A dermatologist weighs in on the experimental triple-action drug retatrutide. No further detail is given beyond the hashtags on the clip.
Recap by typeshit. Post by Facebook on Facebook.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Dr. Noc joined StarTalk to cover GLP-1 drugs, creatine, peptides and looksmaxxing. The full talk is out on YouTube and in podcast apps.
The obesity doctor says commenters once treated her early support for these medications as heresy. She adds that she saw their potential back in 2005.
A TikTok playlist collects GLP-1 updates from creator @stephaniemua1. There is no detail on what the videos cover beyond the playlist name.
Pannu points to over $8B in upfront FGF21 deals and 500+ assets in development, and says the commercial and clinical split is arriving unusually early.
Free Malaysia Today reports that price is holding back use of weight loss drugs in developing markets, where penetration rates remain low.
Loading…